Thus, ERK3/MK5 represents a previously unrecognized signaling axis in adipose tissue and an attractive target for future therapies aiming to combat obesity-induced diabetes. The gene discussed is MAPKAPK5; the disease is obesity due to melanocortin 4 receptor deficiency.